Dmitry Kobyzev
Deputy Head of Pharmstandard Ventures
Deputy Head of Pharmstandard Ventures
PHS VENTURES
Russian Federation
Biography
Dmitry Kobyzev joined Pharmstandard Ventures (formerly Inbio Ventures) in 2014. Prior to that he served as an Investment Director of one of the top Russian life science venture capital teams focusing on international transactions at a sovereign development capital fund. From 2005 to 2010, Dr. Kobyzev advised international private equity and corporate clients at the transactions practice of PricewaterhouseCoopers. Dr. Kobyzev is a member of the Board of Directors of TransMedics, Inc. and served on the Board of Proteon Therapeutics Inc. between 2014-2016. Dr. Kobyzev received a B.A. and a Ph.D. degree in economics from Moscow State University.
Research Interest
Dmitry Kobyzev joined Pharmstandard Ventures (formerly Inbio Ventures) in 2014. Prior to that he served as an Investment Director of one of the top Russian life science venture capital teams focusing on international transactions at a sovereign development capital fund. From 2005 to 2010, Dr. Kobyzev advised international private equity and corporate clients at the transactions practice of PricewaterhouseCoopers. Dr. Kobyzev is a member of the Board of Directors of TransMedics, Inc. and served on the Board of Proteon Therapeutics Inc. between 2014-2016. Dr. Kobyzev received a B.A. and a Ph.D. degree in economics from Moscow State University.
